SG11202101235QA - Compositions and methods for treating sexual dysfunction and enhancing sexual response and pleasure - Google Patents

Compositions and methods for treating sexual dysfunction and enhancing sexual response and pleasure

Info

Publication number
SG11202101235QA
SG11202101235QA SG11202101235QA SG11202101235QA SG11202101235QA SG 11202101235Q A SG11202101235Q A SG 11202101235QA SG 11202101235Q A SG11202101235Q A SG 11202101235QA SG 11202101235Q A SG11202101235Q A SG 11202101235QA SG 11202101235Q A SG11202101235Q A SG 11202101235QA
Authority
SG
Singapore
Prior art keywords
pleasure
compositions
methods
enhancing
sexual
Prior art date
Application number
SG11202101235QA
Inventor
Dennis Jenn
Original Assignee
Ilylt Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/056,726 external-priority patent/US10220063B2/en
Priority claimed from US16/170,446 external-priority patent/US10555927B2/en
Application filed by Ilylt Llc filed Critical Ilylt Llc
Publication of SG11202101235QA publication Critical patent/SG11202101235QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SG11202101235QA 2018-08-07 2018-11-07 Compositions and methods for treating sexual dysfunction and enhancing sexual response and pleasure SG11202101235QA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16/056,726 US10220063B2 (en) 2013-11-11 2018-08-07 Compositions and methods for enhancing sexual pleasure and performance
US16/170,446 US10555927B2 (en) 2013-11-11 2018-10-25 Compositions and methods for enhancing sexual pleasure and performance
PCT/US2018/059712 WO2020032988A1 (en) 2018-08-07 2018-11-07 Compositions and methods for treating sexual dysfunction and enhancing sexual response and pleasure

Publications (1)

Publication Number Publication Date
SG11202101235QA true SG11202101235QA (en) 2021-03-30

Family

ID=69414996

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202101235QA SG11202101235QA (en) 2018-08-07 2018-11-07 Compositions and methods for treating sexual dysfunction and enhancing sexual response and pleasure

Country Status (9)

Country Link
EP (1) EP3833341A4 (en)
JP (1) JP2021535195A (en)
KR (1) KR20210042350A (en)
CN (1) CN112839645A (en)
AU (1) AU2018436267B2 (en)
BR (1) BR112021002323A2 (en)
MX (1) MX2021001333A (en)
SG (1) SG11202101235QA (en)
WO (1) WO2020032988A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020086655A2 (en) * 2018-10-23 2020-04-30 Rivera John V Methods and treatments for erectile dysfunction
WO2022027122A1 (en) * 2020-08-06 2022-02-10 Ramade & Cia Holding Corp. Compositions with cannabinoids of cannabis sativa for treating erectile and sexual dysfunction

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005007166A1 (en) * 2003-07-16 2005-01-27 Pfizer Limited Treatment of sexual dysfunction
MX2015013202A (en) * 2013-03-15 2016-04-07 Biotech Inst Llc Breeding, production, processing and use of specialty cannabis.
US10064905B1 (en) * 2013-11-11 2018-09-04 Ilysm, LLC Pharmaceutical preparation
WO2018089863A1 (en) * 2016-11-11 2018-05-17 Bennes, Inc. Formulations for efficient delivery of cannabinoids
US10568847B2 (en) * 2016-12-13 2020-02-25 James J. Caprio Compositions and methods for treatment of erectile dysfunction

Also Published As

Publication number Publication date
EP3833341A4 (en) 2022-05-04
EP3833341A1 (en) 2021-06-16
MX2021001333A (en) 2021-06-23
JP2021535195A (en) 2021-12-16
AU2018436267B2 (en) 2024-06-27
BR112021002323A2 (en) 2021-05-04
KR20210042350A (en) 2021-04-19
WO2020032988A1 (en) 2020-02-13
CN112839645A (en) 2021-05-25
AU2018436267A1 (en) 2021-03-18

Similar Documents

Publication Publication Date Title
GB2578539B (en) Compositions and methods for preventing or treating muscle conditions
IL275626A (en) Surface treatment compositions and methods
IL279265A (en) Compositions and methods for treating immune thrombocytopenia
EP3307280A4 (en) Treatment of sexual dysfunction
EP3506860A4 (en) Methods and devices for treating erectile dysfunction
IL270114B1 (en) Methods and compositions for treating neurological disorders
IL280348A (en) Surface treatment compositions and methods
ZA201905609B (en) Compositions and methods for improving sexual function
IL272246A (en) Compositions and methods for treating galactosemia
IL269743A (en) Methods and compositions for treating retina-associated disease using ccr3-inhibitors
IL290348A (en) Surface treatment compositions and methods
IL277463A (en) Compositions and methods for treating pruritus
IL273850A (en) Compositions and methods for treatment of fibrosis
ZA201908451B (en) Treatment of sexual dysfunction and improvement in sexual quality of life
SG11202101235QA (en) Compositions and methods for treating sexual dysfunction and enhancing sexual response and pleasure
EP3681520A4 (en) Compositions and methods for treating liver disease and dysfunction
EP3532031A4 (en) Treating sexual dysfunction
IL282739A (en) Compositions and methods for the treatment of smooth muscle dysfunction
EP3565541A4 (en) Treatment of sexual dysfunction
IL279907A (en) Compositions and methods for treating stroke
EP3389715A4 (en) Compositions and methods for treating cardiac dysfunction
IL277152A (en) Compositions and methods for treating cutaneous fibrosis
EP3609330A4 (en) Compositions and methods for treating water
GB201910028D0 (en) Sexual pleasure enhancement compositions
EP3445384C0 (en) Composition for treating diastolic dysfunction